Skip to main content
. 2020 Jun 22;16:211. doi: 10.1186/s12917-020-02429-w

Table 5.

Flunixin and 5-hydroxyflunixin concentrations (ng/mL) in urine and oral fluids after intramuscular administration of flunixin meglumine at 2.2 mg/kg in finishing-age swine

Group Pig ID Urine Pen-Level Oral Fluids
Flunixin 5-hydroxyflunixin Flunixin 5-hydroxyflunixin

G1

(Day 1)

260 9459.1 1295.0 168.6 21.0
261 3762.5 972.0
270 (C) 231.4 16.5
273 3032.0 724.4

G2

(Day 4)

262 60.3 <LOQ 16.8 10.9
264 22.7 <LOQ
269 35.5 <LOQ
274 (C) 11.6 <LOQ

G3

(Day 8)

258 <LOQ <LOQ <LOQ <LOQ
266 (C) <LOQ NF
268 <LOQ NF
272 <LOQ NF

G4

(Day 12)

263 NF NF 12.3 11.3
267 <LOQ NF
271 <LOQ NF
275 (C) <LOQ NF

G5

(Day 16)

257 NF NF <LOQ 10.6
259 NF NF
265 (C) NF NF
276 NF NF

Note: Oral fluids were a group sample from all four pigs in the group at the day of necropsy. Concentrations that were below the level of quantification (LOQ) were designated “LOQ”. For this assay the LOQ was 5 ng/mL. If no flunixin or 5-hydroxyflunixin levels were detected, the sample was designated “NF”. Untreated, control pigs used to assess the potential for environmental contamination were designated (C)